Cardiac development: New concepts

Clinics in Perinatology

Volumn 32, Issue 4, 2005, Pages 845-855

  Gruber, Peter J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME DELETION; CONGENITAL HEART DISEASE; DEVELOPMENTAL BIOLOGY; DIGEORGE SYNDROME; EPIGENETICS; FINANCIAL MANAGEMENT; GENETIC LINKAGE; HEALTH CARE POLICY; HEART DEVELOPMENT; HUMAN; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

GATA4 TRANSCRIPTION FACTOR; HEART; HEART DEFECTS, CONGENITAL; HUMANS; MUTATION; T-BOX DOMAIN PROTEINS;

EID: 28444469253     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2005.09.003     Document Type: Review

References (47)

1. J.I. Hoffman Incidence of congenital heart disease: I. Postnatal incidence Pediatr Cardiol 16 1995 103 113
2. J.I. Hoffman, and S. Kaplan The incidence of congenital heart disease J Am Coll Cardiol 39 2002 1890 1900
3. J.N. Poynter, S.B. Gruber, and P.D. Higgins Statins and the risk of colorectal cancer N Engl J Med 352 2005 2184 2192
4. M.W. Foster, and R.R. Sharp Beyond race: towards a whole-genome perspective on human populations and genetic variation Nat Rev Genet 5 2004 790 796
5. Department of Energy/National Institutes of Health DOE-NIH guidelines for sharing data and resources policy Human Genome News 4 1992 4
6. Czech T. Sharing publication-related and materials: responsibilities of authorship in the life sciences. Washington, DC: The National Academy Press. p. 1-16
7. N.R. Cozzarelli UPSIDE: uniform principle for sharing integral data and materials expeditiously Proc Natl Acad Sci USA 101 2004 3721 3722
8. C.B. Brown, L. Feiner, and M.M. Lu PlexinA2 and semaphorin signaling during cardiac neural crest development Development 128 2001 3071 3080
9. L. Feiner, A.L. Webber, and C.B. Brown Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption Development 128 2001 3061 3070
10. S. Jarriault, C. Brou, and F. Logeat Signalling downstream of activated mammalian Notch Nature 377 1995 355 358
11. L. Li, I.D. Krantz, and Y. Deng Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1 Nat Genet 16 1997 243 251
12. V. McKusick DiGeorge syndrome Online Mendelian inheritance in man 2004 Available at: http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=188400
13. G. Tiller, and V. McKusick T-box 1 Online Mendelian inheritance in man 2005 Available at: http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=602054
14. T.F. Plageman Jr, and K.E. Yutzey T-box genes and heart development: putting the "T" in heart Dev Dyn 232 2005 11 20
15. J.A. Epstein Developing models of DiGeorge syndrome Trends Genet 17 Suppl 2001 S13 S17
16. N. Galili, H.S. Baldwin, and J. Lund A region of mouse chromosome 16 is syntenic to the DiGeorge, velocardiofacial syndrome minimal critical region Genome Res 7 1997 399
17. J. Lund, B. Roe, and F. Chen Sequence-ready physical map of the mouse chromosome 16 region with conserved synteny to the human velocardiofacial syndrome region on 22q11.2 Mamm Genome 10 1999 438 443
18. E.A. Lindsay, A. Botta, and V. Jurecic Congenital heart disease in mice deficient for the DiGeorge syndrome region Nature 401 1999 379 383
19. L.A. Jerome, and V.E. Papaioannou DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1 Nat Genet 27 2001 286 291
20. E.A. Lindsay, F. Vitelli, and H. Su Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice Nature 410 2001 97 101
21. S. Merscher, B. Funke, and J.A. Epstein TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome Cell 104 2001 619 629
22. J. Liao, L. Kochilas, and S. Nowotschin Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage Hum Mol Genet 13 2004 1577 1585
23. T. Piotrowski, D.G. Ahn, and T.F. Schilling The zebrafish van gogh mutation disrupts tbx1, which is involved in the DiGeorge deletion syndrome in humans Development 130 2003 5043 5052
24. H. Yagi, Y. Furutani, and H. Hamada Role of TBX1 in human del22q11.2 syndrome Lancet 362 2003 1366 1373
25. C.B. Brown, J.M. Wenning, and M.M. Lu Cre-mediated excision of Fgf8 in the Tbx1 expression domain reveals a critical role for Fgf8 in cardiovascular development in the mouse Dev Biol 267 2004 190 202
26. T. Hu, H. Yamagishi, and J. Maeda Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors Development 131 2004 5491 5502
27. J.B. Burch Regulation of GATA gene expression during vertebrate development Semin Cell Dev Biol 16 2005 71 81
28. T. Peterkin, A. Gibson, and M. Loose The roles of GATA-4, -5 and -6 in vertebrate heart development Semin Cell Dev Biol 16 2005 83 94
29. R. Shimizu, and M. Yamamoto Gene expression regulation and domain function of hematopoietic GATA factors Semin Cell Dev Biol 16 2005 129 136
30. T. Pehlivan, B.R. Pober, and M. Brueckner GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease Am J Med Genet 83 1999 201 206
31. V. Garg, I.S. Kathiriya, and R. Barnes GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5 Nature 424 2003 443 447
32. D. Wang, P.S. Chang, and Z. Wang Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor Cell 105 2001 851 862
33. D.Z. Wang, S. Li, and D. Hockemeyer Potentiation of serum response factor activity by a family of myocardin-related transcription factors Proc Natl Acad Sci USA 99 2002 14855 14860
34. J. Li, X. Zhu, and M. Chen Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development Proc Natl Acad Sci USA 102 2005 8916 8921
35. Z. Niu, W. Yu, and S.X. Zhang Conditional mutagenesis of the murine serum response factor gene blocks cardiogenesis and the transcription of downstream gene targets J Biol Chem 280 2005 32531 32538
36. D.Z. Wang, and E.N. Olson Control of smooth muscle development by the myocardin family of transcriptional coactivators Curr Opin Genet Dev 14 2004 558 566
37. T.A. McKinsey, and E.N. Olson Toward transcriptional therapies for the failing heart: chemical screens to modulate genes J Clin Invest 115 2005 538 546
38. T.A. McKinsey, C.L. Zhang, and E.N. Olson Control of muscle development by dueling HATs and HDACs Curr Opin Genet Dev 11 2001 497 504
39. P.M. Nolan, J. Peters, and M. Strivens A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse Nat Genet 25 2000 440 443
40. W.C. Skarnes, H. von Melchner, and W. Wurst A public gene trap resource for mouse functional genomics Nat Genet 36 2004 543 544
41. C.P. Austin, J.F. Battey, and A. Bradley The knockout mouse project Nat Genet 36 2004 921 924
42. J. Auwerx, P. Avner, and R. Baldock The European dimension for the mouse genome mutagenesis program Nat Genet 36 2004 925 927
43. T. Gura A silence that speaks volumes Nature 404 2000 804 808
44. S.M. Hammond, A.A. Caudy, and G.J. Hannon Post-transcriptional gene silencing by double-stranded RNA Nat Rev Genet 2 2001 110 119
45. R.S. Haltiwanger, and J.B. Lowe Role of glycosylation in development Annu Rev Biochem 73 2004 491 537
46. L. Wells, and G.W. Hart O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar FEBS Lett 546 2003 154 158
47. Y. Takada, F.R. Khuri, and B.B. Aggarwal Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NF-kappaB-regulated gene expression and up-regulation of apoptosis J Biol Chem 279 2004 26287 26299